| 21-06-25 | NattoPharma ASA : - Delisting | AQ |
| 21-06-15 | NattoPharma : Received application for delisting | AQ |
| 21-06-14 | NattoPharma : Annual General Meeting in NattoPharma ASA | AQ |
| 21-06-10 | NattoPharma : OSLO BØRS - SUSPENDED | AQ |
| 21-06-09 | NattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisition | AQ |
| 1 day | +2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kjetil Ramsøy
CEO | Chief Executive Officer | 54 | 2018-02-07 |
Robert Schrama
DFI | Director of Finance/CFO | - | 2020-03-08 |
Gunilla Traberg
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frode Marc Bohan
CHM | Chairman | 58 | 2004-11-03 |
| Director/Board Member | 52 | 2011-01-31 | |
Kjetil Ramsøy
BRD | Director/Board Member | 54 | 2015-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.35% | +1.46% | - | - | 86.2M | |
| +3.04% | +4.80% | +61.45% | +127.47% | 1,133B | |
| +4.36% | +6.28% | +39.52% | +77.81% | 621B | |
| -0.07% | +0.44% | +24.47% | +96.67% | 503B | |
| +0.03% | +3.27% | +39.79% | +65.06% | 379B | |
| -0.64% | +2.13% | +69.25% | +43.47% | 370B | |
| +1.58% | +2.37% | +22.91% | +52.52% | 292B | |
| +2.90% | +2.22% | +3.51% | +28.51% | 262B | |
| +2.37% | +3.44% | +51.68% | +64.41% | 237B | |
| +2.21% | -0.27% | +29.21% | +102.35% | 190B | |
| Average | +1.75% | +3.22% | +37.98% | +73.14% | 443.11B | |
| Weighted average by Cap. | +1.97% | +3.73% | +43.28% | +85.18% |
Employees
18
Sector
Pharmaceuticals
